[
1. Moore BB, Hogaboam CM. Animal model of human lung disease. Am J Physiol Lung Cell Mol Physiol 2008; 294: 152-60.
]Search in Google Scholar
[
2. Fujimoto H, Kobayashi T, Azuma A. Idiopathic Pulmonary Fibrosis: treatment and prognosis. Clin Med Insights Circ Respir Pulm Med 2016; 9: 179-85.
]Search in Google Scholar
[
3. Carrington R, Jordan S, Pitchford SC, Page CP. Use of animal models in IPF research. Pulm Pharmacol Ther 2018; 51: 73-8.
]Search in Google Scholar
[
4. Sanchez VC, Pietruska JR, Miselis NR, et al. Biopersistence and potential adverse health impacts of fibrous nanomaterials: what have we learned from asbestos? Wiley Interdiscip Rev Nanomed Nanobiotechnol 2009; 1: 511-29.
]Search in Google Scholar
[
5. Takita T, Muraoka Y, Nakatani T, et al. Metal-complex of bleomycin and its implication for the mechanism of bleomycin action. J Antibiot 1978; 31: 1073-7.
]Search in Google Scholar
[
6. Della Latta V, Cecchettini A, Del Ry S, et al. Bleomycin in the setting of lung fibrosis induction: from biological mechanisms to counteractions. Pharmacol Res 2015; 97: 122-30.
]Search in Google Scholar
[
7. Claussen CA, Long EC. Nucleic Acid recognition by metal complexes of bleomycin. Chem Rev 1999; 99: 2797-816.
]Search in Google Scholar
[
8. Sato K, Tashiro Y, Chibana S, et al. Role of lipid-derived free radical in bleomycin-induced lung injury in mice: availability for ESR spin trap method with organic phase extraction. Biol Pharm Bull 2008; 31: 1855-9.
]Search in Google Scholar
[
9. Chaudhary NI, Schnapp A, Park JE. Pharmacologic differentiation of inflammation and fibrosis in the rat bleomycin model. Am J Respir Crit Care Med 2006; 173: 769-76.
]Search in Google Scholar
[
10. Sebti SM, Mignano JE, Jani JP, et al. Bleomycin hydrolase: molecular cloning, sequencing, and biochemical studies reveal membership in the cysteine proteinase family. Biochemistry 1989; 28: 6544-8.
]Search in Google Scholar
[
11. Tomášková V Jr, Rozborilová E, Flochová E, Staško J, Kubisz P. Effect of cytostatic drugs on the endothelium and platelets. Acta Med Mart 2002; 2: 20-3.
]Search in Google Scholar
[
12. Fleischman RW, Baker JR, Thompson GR, et al. Bleomycin-induced interstitial pneumonia in dogs. Thorax 1971; 26: 675-82.
]Search in Google Scholar
[
13. Adamson IY, Bowden DH. The pathogenesis of bleomycin-induced pulmonary fibrosis in mice. Am J Pathol 1974; 77: 185-97.
]Search in Google Scholar
[
14. Thrall RS, Mccormick JR, Jack RM, et al. Bleomycin-induced pulmonary fibrosis in the rat: inhibition by indomethacin. Am J Pathol 1979; 95: 117-30.
]Search in Google Scholar
[
15. Bale S, Sunkoju M, Reddy SS, et al. Oropharyngeal aspiration of bleomycin: An alternative experimental model of pulmonary fibrosis developed in Swiss mice. Indian J Pharmacol 2016; 48: 643–8.
]Search in Google Scholar
[
16. Egger C, Cannet C, Gérard C, et al. Administration of Bleomycin via the Oropharyngeal Aspiration Route Leads to Sustained Lung Fibrosis in Mice and Rats as Quantified by UTE-MRI and Histology. PLoS One 2013; 8: e63432.
]Search in Google Scholar
[
17. Zhao J, Shi W, Wang YL, et al. Smad3 deficiency attenuates bleomycin-induced pulmonary fibrosis in mice. Am J Physiol Lung Cell Mol Physiol 2002; 282: 585-93.
]Search in Google Scholar
[
18. Wollin L, Wex E, Pautsch A, et al. Mode of action of nintedanib in the treatment of idiopathic pulmonary fibrosis. Eur Respir J 2015; 45: 1434-45.
]Search in Google Scholar
[
19. Wollin L, Maillet I, Quesniaux V, et al. Antifibrotic and anti-inflammatory activity of the tyrosine kinase inhibitor nintedanib in experimental models of lung fibrosis. J Pharmacol Exp Ther 2014; 349: 209-20.
]Search in Google Scholar
[
20. Oku H, Shimizu T, Kawabata T, et al. Antifibrotic action of pirfenidone and prednisolone: different effects on pulmonary cytokines and growth factors in bleomycin-induced murine pulmonary fibrosis. Eur J Pharmacol 2008; 590: 400-8.
]Search in Google Scholar
[
21. Maher TM. Pirfenidone in idiopathic pulmonary fibrosis. Drugs Today (Barc) 2010; 46: 473-82.
]Search in Google Scholar
[
22. Liu W, Wan J, Han JZ, et al. Antiflammin-1 attenuates bleomycin-induced pulmonary fibrosis in mice. Respir Res 2013; 14: 101.
]Search in Google Scholar
[
23. Li YJ, Azuma A, Usuki J, et al. EM703 improves bleomycin-induced pulmonary fibrosis in mice by the inhibition of TGF-beta signaling in lung fibroblasts. Respir Res 2006; 7: 16.
]Search in Google Scholar
[
24. Ji Y, Dou YN, Zhao QW, et al. Paeoniflorin suppresses TGF- mediated epithelial-mesenchymal transition in pulmonary fibrosis through a Smad-dependent pathway. Acta Pharmacol Sin 2016; 37: 794-804.
]Search in Google Scholar
[
25. Tang H, He H, Ji H, et al. Tanshinone IIA ameliorates bleomycin-induced pulmonary fibrosis and inhibits transforming growth factor-beta-dependent epithelial to mesenchymal transition. J Surg Res 2015; 197: 167-75.
]Search in Google Scholar
[
26. Degryse AL, Tanjore H, Xu XC, et al. Repetitive intratracheal bleomycin models several features of idiopathic pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 2010; 299: 442-52.
]Search in Google Scholar
[
27. Izbicki G, Segel MJ, Christensen TG, et al. Time course of bleomycin-induced lung fibrosis. Int J Exp Pathol 2002; 83: 111-9.
]Search in Google Scholar
[
28. Peng R, Sridhar S, Tyagi G, et al. Bleomycin induces molecular changes directly relevant to idiopathic pulmonary fibrosis: a model for “active” disease. PLoS One 2013; 8: e59348.
]Search in Google Scholar
[
29. Chua F, Gauldie J, Laurent GJ. Pulmonary fibrosis: searching for model answers. Am J Respir Cell Mol Biol 2005; 33: 9–13.
]Search in Google Scholar
[
30. Moore BB, Murray L, Das A, et al. The role of CCL12 in the recruitment of fibrocytes and lung fibrosis. Am J Respir Cell Mol Biol 2006; 35: 175–81.
]Search in Google Scholar
[
31. Roberts SN, Howie SE, Wallace WA, et al. A novel model for human interstitial lung disease: hapten-driven lung fibrosis in rodents. J Pathol 1995; 176: 309-18.
]Search in Google Scholar
[
32. Christensen PJ, Goodman RE, Pastoriza L, et al. Induction of lung fibrosis in the mouse by intratracheal instillation of fluorescein isothiocyanate is not T-cell-dependent. Am J Pathol 1999; 155: 1773-9.
]Search in Google Scholar
[
33. Degryse AL, Lawson WE. Progress toward improving animal models for idiopathic pulmonary fibrosis. Am J Med Sci 2011; 341: 444-9.
]Search in Google Scholar
[
34. Karvonen RL, Fernandez-Madrid F, Maughan RL, et al. An animal model of pulmonary radiation fibrosis with biochemical, physiologic, immunologic, and morphologic observations. Radiat Res 1987; 111: 68-80.
]Search in Google Scholar
[
35. Haston CK, Travis EL. Murine susceptibility to radiation-induced pulmonary fibrosis is influenced by a genetic factor implicated in susceptibility to bleomycin-induced pulmonary fibrosis. Cancer Res 1997; 57: 5286-91.
]Search in Google Scholar
[
36. Morgan GW, Breit SN. Radiation and the lung: a reevaluation of the mechanisms mediating pulmonary injury. Int J Radiat Oncol Biol Phys 1995; 31: 361-9.
]Search in Google Scholar
[
37. Paun A, Kunwar A, Haston CK. Acute adaptive immune response correlates with late radiation-induced pulmonary fibrosis in mice. Radiat Oncol 2015; 10: 45.
]Search in Google Scholar
[
38. Lakatos HF, Burgess HA, Thatcher TH, et al. Oropharyngeal aspiration of a silica suspension produces a superior model of silicosis in the mouse when compared to intratracheal instillation. Exp Lung Res 2006; 32: 181-99.
]Search in Google Scholar
[
39. Davis GS, Leslie KO, Hemenway DR. Silicosis in mice: effects of dose, time, and genetic strain. J Environ Pathol Toxicol Oncol 1998; 17: 81-97.
]Search in Google Scholar
[
40. Barbarin V, Nihoul A, Misson P, et al. The role of pro- and anti-inflammatory responses in silica-induced lung fibrosis. Respir Res 2005; 6: 112.
]Search in Google Scholar
[
41. Barbarin V, Arras M, Misson P, et al. Characterization of the effect of interleukin-10 on silica-induced lung fibrosis in mice. Am J Respir Cell Mol Biol 2004; 31: 78–85.
]Search in Google Scholar
[
42. Hurbánková M, Kaiglová A, Buchancová J. Cytokines – the important biomarkers of lung injury after exposure to indstrial fibrous dusts. Acta Med Mart 2001; 1: 19-24.
]Search in Google Scholar
[
43. Roggli V, Gibbs AR, Attanoos R, et al. Pathology of asbestosis: an update of the diagnostic criteria response to a critique. Arch Pathol Lab Med 2016; 140: 950-2.
]Search in Google Scholar
[
44. Kim SJ, Cheresh P, Jablonski RP, et al. The role of mitochondrial DNA in mediating alveolar epithe lial cell apoptosis and pulmonary fibrosis. Int J Mol Sci 2015; 16: 21486-519.
]Search in Google Scholar
